Explanation to the intimation filed on 29th March, 2025 regarding reasoning for the resignation of Chief Financial Officer of the Company.

Cfo ResignedKmp ResignedManagement Changes View source PDF Explain this filing

MANGALAM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.7%Reaction day

₹24.05

prior close

₹24.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.5%-1.1% vs market

Pharmaceuticals peers, median of 153sector-0.5%-1.2% vs sector

On the reaction day the stock moved 1.1 pts less than Nifty Microcap 250 and 1.2 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.1

15m

-0.2

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.7-0.5-1.1-0.5-1.2

Next day

+3.8-1.3+5.1-1.3+5.1

+8.9-1.4+10.3-1.5+10.4

+14.4+0.0+14.4-0.6+15.0

+20.1+0.2+19.8-0.7+20.8

+26.1+1.2+24.9+0.3+25.7

+39.0+0.8+38.2+0.2+38.8

15d

+105.2-5.1+110.3-4.2+109.4

+75.5-8.8+84.3-7.9+83.4

+23.5-4.5+28.0-6.2+29.7

+18.3-13.7+32.0-15.2+33.5

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 153Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mangalam Drugs & Organics Ltd has clarified the reason behind the resignation of its Chief Financial Officer, Mr. Ajay Samant, which was previously intimated on March 29, 2025. The Company had inadvertently omitted the reason for resignation in the earlier filing. As per office guidelines on retirement age, Mr. Samant tendered his resignation on March 28, 2025, effective March 31, 2025. The Board noted the resignation at its meeting on March 29, 2025. The letter was signed by Chairman & Managing Director Govardhan M. Dhoot and filed with BSE on December 24, 2025.

Likely market impact

This is a routine KMP change due to retirement-age policy, not a governance red flag. Shareholders should note the CFO position needs a replacement, but no negative implication for the stock is suggested.